Enabling breakthroughs from benchtop to bedside.

Driving innovation across the product life cycle requires multi-faceted expertise. From scientific directors to formulary directors, Precision Medicine Group has amassed a team of industry leaders who provide deep insight at every milestone.

These leaders, collaborating within the multifaceted services at Precision Medicine Group, bring together the combination of skills needed for next generation drug development and commercialization.

NEXT-GEN CLINICAL DEVELOPMENT

Accelerating drug development with clinical, biomarker, and regulatory solutions.

Precision for Medicine

Clinical, biomarker, and regulatory solutions

Precision for Medicine
Oncology and Rare Disease

Fully integrated CRO devoted to oncology and rare disease

QuartzBio

AI powered bio-informatics for translational research and clinical development

NEXT-GEN COMMERCIALIZATION

Expressing the value of medical and diagnostic breakthroughs to maximize market potential for key stakeholders.

Precision for Value

Advances payer marketing through experiential strategy, effective value demonstration, and market access-focused resource development

precisioneffect

Drives adoption for disruptive innovations with providers, patients, and consumers leveraging behavioral science and analytics, breakthrough creative and cutting-edge brand experiences

Precision Health Economics

Synthesizes clinical value and societal value of therapies to derive competitive and strategic cost models for therapies

Precision Xtract

Extracts and unlocks the most critical insights from real-world data to drive global market access strategies and optimize market penetration

ETHOS Health Communications

Leverages scientific rigor and commitment to quality to develop and communicate a clear and compelling scientific story to healthcare providers

Stern Investor Relations

Provides premier investor relations services to the entrepreneurial healthcare and biotechnology sectors and represents prominent worldwide public and private companies across all market capitalizations, therapeutic areas and stages of development